References1 Oleson, J. J.; Sloboda, A.; Troy, W. P.; et al.. J Am Chem Soc. 1955, 77, 6713.2 Ciotti, M. M.; Humphreys, S. R.; Venditti, J. M.; et al.. Cancer Res. 1960, 20, 1195.3 Tsukamoto, K.; Suno, M.; Igarashi, K., et al.. Cancer Res. 1975, 35, 2631.4 Nelson, J. A.; Rose, L. M.; Bennett, L. L Cancer Res. 1976, 36, 1375.5 Miyamoto, K.; Koshiura, R., Moru M. et al.. Chem Pharm Bull. 1985, 33, 5126.6 Miyahara, M.; Nakadate, M.; Sueyoshi, S.; et al.. Chem Pharm Bull. 1982, 30, 4402.7 Krakoff, I. H.; Balis, M. E. J Clin Invest. 1959, 38, 907.8 Stewart, J. A.; Ackerly, C. C.; Myers, C. F.; et al.. Cancer Chemother Pharmacol. 1986, 16, 287.9 Shevrin, D. H.; McGuire, W. P.; Lanzotti, V.; et al.. Carncer Treat. Rep. 1986, 70, 417.10 Gujral, M. S.; Patnaik, P. M.; Kaul, R.; et al.. Cancer Chemother. Pharmacol. 2001, 47, S23.11 Asbury, R.; Blessing, J. A.; Moore, D. Am J Clin Oncol. 1996, 19(4), 400.12 Locker, G. Y.; Kilton, L.; Khandekar, J. D.; et al.. Invest New Drugs. 1994, 12(4), 299.13 Foroumadi, A.; Soltani, F.; Moallemzadeh-Haghighi, H.; et al.. Arch. Pharm. 2005, 338, 112.14 Stockler, M. R.; Wilcken, N. J. C.; Coates, A. Breast Cancer Res. Treat. 2003, 81, 49.15 Senff-Ribeiro, A.; Echevarria, A.; Silva, E. F.; et al..Anticancer Drugs. 2004, 15, 269.16 Matysiak, J.; Niewiadomy, A. Synthetic Commun. 2006, 36, 1621.17 Matysiak, J.; Opolski, A. Bioorg. Med. Chem. 2006, 14, 4483–448918 Rzeski, Wojciech.; Matysiak, J.; Kandefer-Szerszen, M. Bioorg. Med. Chem. 2007, 15 , 3201–320719 Hu, B.-F.;Li, Z.-M, Chem.J.ChineseUniversities, 1987,8(9),802 (in Chinese). (胡秉方, 李增民, 高等学校化学学报, 1987,8(9),802.)20 Xu, S.-Y. Pharmacological experiments methodology.Beijing, People's Medical Publishing House, 1994:1424-1430 (in Chinese).(许叔云, 药理实验方法学, 1994:1424-1430 ) |